These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16237192)

  • 21. Shape and steepness of toxicological dose-response relationships of continuous endpoints.
    Slob W; Setzer RW
    Crit Rev Toxicol; 2014 Mar; 44(3):270-97. PubMed ID: 24252121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
    Cox LA
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics and dose optimisation of carboplatin.
    Duffull SB; Robinson BA
    Clin Pharmacokinet; 1997 Sep; 33(3):161-83. PubMed ID: 9314610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of environmental parameters (temperature, pH and a(w)) on the individual cell lag phase and generation time of Listeria monocytogenes.
    Francois K; Devlieghere F; Standaert AR; Geeraerd AH; Van Impe JF; Debevere J
    Int J Food Microbiol; 2006 May; 108(3):326-35. PubMed ID: 16488043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A semiparametric approach to analysing dose-response data.
    Nottingham QJ; Birch JB
    Stat Med; 2000 Feb; 19(3):389-404. PubMed ID: 10649304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response relationship for radiation therapy of subclinical disease.
    Withers HR; Peters LJ; Taylor JM
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):353-9. PubMed ID: 7836089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologically effective dose distribution based on the linear quadratic model and its clinical relevance.
    Lee SP; Leu MY; Smathers JB; McBride WH; Parker RG; Withers HR
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):375-89. PubMed ID: 7673025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicology and carcinogenesis studies of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Jan; (545):1-240. PubMed ID: 18685716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introducing Biological Microdosimetry for Ionising Radiation.
    Scott BR; Schöllnberger H
    Radiat Prot Dosimetry; 2000 Oct; 91(4):377-384. PubMed ID: 29921103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers.
    Lim KS; Kwon JS; Jang IJ; Jeong JM; Lee JS; Kim HW; Kang WJ; Kim JR; Cho JY; Kim E; Yoo SY; Shin SG; Yu KS
    Clin Pharmacol Ther; 2007 Feb; 81(2):252-8. PubMed ID: 17259948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Unified Probabilistic Framework for Dose-Response Assessment of Human Health Effects.
    Chiu WA; Slob W
    Environ Health Perspect; 2015 Dec; 123(12):1241-54. PubMed ID: 26006063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone binding and coupled response relationships in systems dependent on the generation of secondary mediators.
    Loeb JN; Strickland S
    Mol Endocrinol; 1987 Jan; 1(1):75-82. PubMed ID: 2842661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):447-59. PubMed ID: 27405818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-triiodothyronine (T3) regulates cellular growth rate, growth hormone production, and levels of nuclear T3 receptors via distinct dose-response ranges in cultured GC cells.
    Halperin Y; Surks MI; Shapiro LE
    Endocrinology; 1990 May; 126(5):2321-6. PubMed ID: 2328689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative cross-species extrapolation in noncancer risk assessment.
    Benignus VA
    Regul Toxicol Pharmacol; 2001 Aug; 34(1):62-8. PubMed ID: 11502157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.